Electromyographic Assessment of the Shoulder Stabilizing Musculature in CrossFit® Athletes

Electromyographic Assessment of the Shoulder Stabilizing Musculature in CrossFit® Athletes. An Observational Analytical Study of Case-controls Prevalence

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT05111652

Enrollment

Registered

2021-11-08

Start date

2021-11-30

Completion date

2021-11-30

Last updated

2021-11-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Electromyography, Muscle Strain, Trapezius Muscle Strain

Keywords

Serratus muscle strain

Brief summary

This is an observational analytical study of prevalent cases and controls.

Detailed description

Approximately 39 subjects who practice CrossFit at least 6 hours a week are invitated to participate in this observational study. It will measure the activation of trapezius and Serratus muscles by Electromyography experiencing a feeling of fatigue 7-8 in PushPress and PullUps.

Interventions

OTHERobservational

observational electromiographic musculature activation

Study design

Observational model

CASE_CONTROL

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to 49 Years

Healthy volunteers

Yes

Inclusion criteria

* Practicing CrossFit® for at least 1 year * A minimum of 6 hours per week CrossFit® training * No shoulder pain at the time of measurement

Exclusion criteria

* Tendinitis * Bursitis * Sistematic disease * Nurological disease * Central or periferic disease

Design outcomes

Primary

Measure	Time frame	Description
Observation of Basal Activation in Trapezius and Serratus muscles and after Push-Press and Pull-Up exercises assessed by Electromyographic mDurance®	10 minutes	Trapezius and Serratus muscle activation analysis in CrossFit athletes with Electromyography system for the muscle activity assessment with the electrode tools

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026